Literature DB >> 16552335

Proliferating cell nuclear antigen, survivin, and CD34 expressions in pancreatic cancer and their correlation with hypoxia-inducible factor 1alpha.

Haiyan Wei1, Chunyou Wang, Libo Chen.   

Abstract

OBJECTIVE: Hypoxia-inducible factor 1alpha (HIF-1alpha) has been universally detected in many types of cells and plays a key role in modulation of tumor-related genes. The purpose of this study was to explore the relationship between HIF-1alpha messenger RNA (mRNA) expression and biologic characteristics in pancreatic cancer, such as tumor angiogenesis, tumor cell proliferation, differentiation, apoptosis, and metastasis.
METHODS: Reverse transcriptase-polymerase chain reaction was used to detect HIF-1alpha mRNA expression. The expressions of survivin, proliferating cell nuclear antigen (PCNA), and CD34 proteins were measured immunohistochemically. The correlation between the expression levels of HIF-1alpha mRNA and survivin, PCNA, and CD34 were analyzed.
RESULTS: There was very significant difference in the expression of HIF-1alpha between the pancreatic cancer tissue and adjacent normal tissue (P < 0.01), but no significant difference was found among tumor histopathologic grades (P > 0.05). There was significant difference in the expression of HIF-1alpha mRNA between Japanese Pancreatic Society stages I to II and stages III to IV (P < 0.05). The expression of HIF-1alpha mRNA was closely correlated with the expression of survivin, PCNA, and CD34 proteins.
CONCLUSION: The expression level of HIF-1alpha mRNA is surmised to have a significant correlation with tumor angiogenesis, cell proliferation, apoptosis, and metastasis. Inhibition of HIF-1alpha may be an important and approachable therapeutic target for pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552335     DOI: 10.1097/01.mpa.0000202961.71600.9b

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  10 in total

Review 1.  Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches.

Authors:  Cristóbal Aguilar-Gallardo; Emily Cecilia Rutledge; Ana M Martínez-Arroyo; Juan José Hidalgo; Santiago Domingo; Carlos Simón
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  Six degrees of separation: the oxygen effect in the development of radiosensitizers.

Authors:  Bryan T Oronsky; Susan J Knox; Jan Scicinski
Journal:  Transl Oncol       Date:  2011-08-01       Impact factor: 4.243

3.  Yin Yang 1 regulates the transcriptional repression of Survivin.

Authors:  Nicholas R Galloway; Carlos J Diaz Osterman; Karl Reiber; Jessica M S Jutzy; Fengzhi Li; Guangchao Sui; Ubaldo Soto; Nathan R Wall
Journal:  Biochem Biophys Res Commun       Date:  2014-02-04       Impact factor: 3.575

4.  Effect of HIF-1alpha on VEGF-C induced lymphangiogenesis and lymph nodes metastases of pancreatic cancer.

Authors:  Jing Tao; Tao Li; Kai Li; Jiongxin Xiong; Zhiyong Yang; Heshui Wu; Chunyou Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

5.  Expression and significance of TLR4 and HIF-1alpha in pancreatic ductal adenocarcinoma.

Authors:  Jian-Jun Zhang; He-Shui Wu; Lin Wang; Yuan Tian; Jing-Hui Zhang; Hai-Long Wu
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

6.  Role of Hypoxia-inducible factor-1 alpha and Survivin in colorectal carcinoma progression.

Authors:  Li-Fang Fan; Wei-Guo Dong; Cong-Qing Jiang; Qun Qian; Qiong-Fang Yu
Journal:  Int J Colorectal Dis       Date:  2008-08-14       Impact factor: 2.571

7.  Hypoxia inducible factor-1 alpha activation of the JCV promoter: role in the pathogenesis of progressive multifocal leukoencephalopathy.

Authors:  Sergio Piña-Oviedo; Kamel Khalili; Luis Del Valle
Journal:  Acta Neuropathol       Date:  2009-04-10       Impact factor: 17.088

Review 8.  Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis.

Authors:  Nicholas R Galloway; Kathryn F Ball; TessaRae Stiff; Nathan R Wall
Journal:  Crit Rev Oncog       Date:  2017

Review 9.  Bringing the heavy: carbon ion therapy in the radiobiological and clinical context.

Authors:  Cody D Schlaff; Andra Krauze; Arnaud Belard; John J O'Connell; Kevin A Camphausen
Journal:  Radiat Oncol       Date:  2014-03-28       Impact factor: 3.481

10.  Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Mol Med       Date:  2013-01-10       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.